Pharmaceutical

Ryan Confer, President and Chief Executive Officer of Genprex, Inc., to Present at Investor Summit Virtual on September 16, 2025

AUSTIN, TX / ACCESS Newswire / September 10, 2025 / Genprex, Inc.'s President and Chief Executive Officer, Ryan Confer, will…

3 months ago

Dermata Therapeutics Announces Strategic Pivot to Over-the-Counter Skin Care Treatments

SAN DIEGO, CA / ACCESS Newswire / September 10, 2025 / Dermata Therapeutics, Inc. (Nasdaq:DRMA)(Nasdaq:DRMAW) ("Dermata" or the "Company"), a…

3 months ago

Revelation Biosciences Announces Special Webcast to Review Positive Top-line Clinical Data

- Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients -- Gemini could…

3 months ago

Hoggan Scientific, LLC Announces Transition to Universal USB-C Charging Connectivity for Its Digital Dynamometers and Force Gauges

Hoggan Products With USB-C Offers Customers Charging Compatibility and Convenience SALT LAKE CITY, UT / ACCESS Newswire / September 10,…

3 months ago

KLAS Highlights Sublimation Health for Outstanding Healthcare Cloud Services

Sublimation Health has been recognized in the KLAS Emerging Company Spotlight Report, an independent evaluation based on direct provider feedback.…

3 months ago

Zomedica and UXR Announce Expanded Distribution Agreement in Canada

Agreement strengthens Canadian veterinarians' access to Zomedica's advanced therapeutic and monitoring solutions ANN ARBOR, MI / ACCESS Newswire / September…

3 months ago

Actuate Therapeutics Announces Pricing of $15.0 Million Public Offering of Common Stock

CHICAGO and FORT WORTH, Texas, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”),…

3 months ago

Artelo Biosciences Announces Publication of Preclinical Data Demonstrating Superior Efficacy and Bioavailability of ART12.11 in Reducing Stress-Induced Depression and Anxiety Symptoms

SOLANA BEACH, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling…

3 months ago

Cumulus Neuroscience Appoints Robert Ballantine to Board of Directors

BELFAST, Northern Ireland, Sept. 10, 2025 /PRNewswire/ -- Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing…

3 months ago

Golden West Companies Integrates Bioz Badges Across Digital Platforms, Delivering Effortless Publication Proof and a Seamless User Experience

PALO ALTO, CALIFORNIA / ACCESS Newswire / September 10, 2025 / Bioz, Inc., an AI technology company transforming how scientists…

3 months ago